These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study. Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114 [TBL] [Abstract][Full Text] [Related]
3. The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Kariyawasam DST; Russell JS; Wiley V; Alexander IE; Farrar MA Genet Med; 2020 Mar; 22(3):557-565. PubMed ID: 31607747 [TBL] [Abstract][Full Text] [Related]
4. Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme. D'Silva AM; Kariyawasam DST; Best S; Wiley V; Farrar MA; Dev Med Child Neurol; 2022 May; 64(5):625-632. PubMed ID: 34839535 [TBL] [Abstract][Full Text] [Related]
6. Variability in Newborn Screening Across Canada: Spinal Muscular Atrophy and Beyond. Groulx-Boivin E; Osman H; Chakraborty P; Lintern S; Oskoui M; Selby K; Van Caeseele P; Wyatt A; McMillan HJ Can J Neurol Sci; 2024 Mar; 51(2):203-209. PubMed ID: 36892082 [TBL] [Abstract][Full Text] [Related]
7. Newborn screening for spinal muscular atrophy in Australia: a non-randomised cohort study. Kariyawasam DS; D'Silva AM; Sampaio H; Briggs N; Herbert K; Wiley V; Farrar MA Lancet Child Adolesc Health; 2023 Mar; 7(3):159-170. PubMed ID: 36669516 [TBL] [Abstract][Full Text] [Related]
8. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go. Dangouloff T; Vrščaj E; Servais L; Osredkar D; Neuromuscul Disord; 2021 Jun; 31(6):574-582. PubMed ID: 33985857 [TBL] [Abstract][Full Text] [Related]
9. Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. Blom M; Bredius RGM; Jansen ME; Weijman G; Kemper EA; Vermont CL; Hollink IHIM; Dik WA; van Montfrans JM; van Gijn ME; Henriet SS; van Aerde KJ; Koole W; Lankester AC; Dekkers EHBM; Schielen PCJI; de Vries MC; Henneman L; van der Burg M; J Clin Immunol; 2021 Jan; 41(1):99-108. PubMed ID: 33070266 [TBL] [Abstract][Full Text] [Related]
10. Parental Burden and Quality of Life in 5q-SMA Diagnosed by Newborn Screening. Kölbel H; Modler L; Blaschek A; Schara-Schmidt U; Vill K; Schwartz O; Müller-Felber W Children (Basel); 2022 Nov; 9(12):. PubMed ID: 36553273 [TBL] [Abstract][Full Text] [Related]
11. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991 [TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands. Velikanova R; van der Schans S; Bischof M; van Olden RW; Postma M; Boersma C Value Health; 2022 Oct; 25(10):1696-1704. PubMed ID: 35963838 [TBL] [Abstract][Full Text] [Related]
14. A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients' and caregivers' perspectives. Ch'ng GS; Koh K; Ahmad-Annuar A; Taib F; Koh CL; Lim ESC Orphanet J Rare Dis; 2022 May; 17(1):200. PubMed ID: 35578241 [TBL] [Abstract][Full Text] [Related]
15. Newborn screening for spinal muscular atrophy in Japan: One year of experience. Sawada T; Kido J; Sugawara K; Yoshida S; Ozasa S; Nomura K; Okada K; Fujiyama N; Nakamura K Mol Genet Metab Rep; 2022 Sep; 32():100908. PubMed ID: 35942129 [TBL] [Abstract][Full Text] [Related]
16. Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project. Ulph F; Wright S; Dharni N; Payne K; Bennett R; Roberts S; Walshe K; Lavender T Health Technol Assess; 2017 Oct; 21(55):1-240. PubMed ID: 28967862 [TBL] [Abstract][Full Text] [Related]
17. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785 [TBL] [Abstract][Full Text] [Related]
18. One Year of Newborn Screening for SMA - Results of a German Pilot Project. Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245 [TBL] [Abstract][Full Text] [Related]
19. [(S)un (M)ay (A)rise on SMA : the hope of a region without spinal muscular atrophy]. Boemer F; Caberg JH; Dideberg V; Beckers P; Marie S; Marcelis L; Bours V; Dangouloff T; Servais L Rev Med Liege; 2019 Sep; 74(9):461-464. PubMed ID: 31486315 [TBL] [Abstract][Full Text] [Related]